Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124790092 | 12479009 | 2 | F | 2016 | 20160704 | 20160620 | 20160707 | EXP | GB-AMGEN-GBRSP2016077635 | AMGEN | 42.00 | YR | A | F | Y | 0.00000 | 20160707 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124790092 | 12479009 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | 125031 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 124790092 | 12479009 | 2 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, 1/1 DAYS | 0 | 80 | MG | QD | |||||||
| 124790092 | 12479009 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, 1/1 DAYS | 0 | 2 | MG | QD | |||||||
| 124790092 | 12479009 | 4 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 124790092 | 12479009 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK UNK, 1 / 3WEEKS | 0 | Q3W | |||||||||
| 124790092 | 12479009 | 6 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 124790092 | 12479009 | 7 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 124790092 | 12479009 | 8 | SS | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124790092 | 12479009 | 1 | Product used for unknown indication |
| 124790092 | 12479009 | 2 | Product used for unknown indication |
| 124790092 | 12479009 | 3 | Product used for unknown indication |
| 124790092 | 12479009 | 4 | Product used for unknown indication |
| 124790092 | 12479009 | 5 | Product used for unknown indication |
| 124790092 | 12479009 | 6 | Product used for unknown indication |
| 124790092 | 12479009 | 7 | Product used for unknown indication |
| 124790092 | 12479009 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124790092 | 12479009 | HO |
| 124790092 | 12479009 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124790092 | 12479009 | Arthralgia | |
| 124790092 | 12479009 | Constipation | |
| 124790092 | 12479009 | Decreased appetite | |
| 124790092 | 12479009 | Deep vein thrombosis | |
| 124790092 | 12479009 | Fatigue | |
| 124790092 | 12479009 | Oral pain | |
| 124790092 | 12479009 | Pain | |
| 124790092 | 12479009 | Pain in extremity | |
| 124790092 | 12479009 | Peripheral swelling | |
| 124790092 | 12479009 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |